We are live on ! Find out more
HCAT icon

Health Catalyst
HCAT

145 hedge funds and large institutions have $154M invested in Health Catalyst in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 38

3% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 33

0% more funds holding

Funds holding: 145 → 145 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.88% less ownership

Funds ownership: 77.81% → 76.93% (-0.88%)

24% less capital invested

Capital invested by funds: $204M → $154M (-$49.9M)

69% less call options, than puts

Call options by funds: $283K | Put options by funds: $913K

Holders
145
Holders Change
–
Holders Change %
0%
% of All Funds
1.9%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
34
Increased
42
Reduced
38
Closed
33
Calls
$283K
Puts
$913K
Net Calls
-$630K
Net Calls Change
-$323K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$5.23M
2
FLAM
First Light Asset Management
Minnesota
+$4.13M
3
Baird Financial Group
Baird Financial Group
Wisconsin
+$2.11M
4
PVM
Palogic Value Management
Texas
+$1.24M
5
AE
AMH Equity
New York
+$797K

Top Sellers

Rank Fund Capital Flow
1
PCM
Portolan Capital Management
Massachusetts
-$7.47M
2
Primecap Management
Primecap Management
California
-$2.11M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$1.79M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$1.17M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
FAM
26
Fred Alger Management
New York
$879K – – –
ZIM
27
Zacks Investment Management
Illinois
$819K +$41.3K +12,066 +4%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$778K +$44.7K +13,072 +5%
Morgan Stanley
29
Morgan Stanley
New York
$691K +$36.7K +10,728 +5%
SPS
30
Susquehanna Portfolio Strategies
Pennsylvania
$656K +$788K +230,345 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$653K +$50.2K +14,653 +7%
Deutsche Bank
32
Deutsche Bank
Germany
$603K -$216K -63,183 -23%
UBS Group
33
UBS Group
Switzerland
$562K +$61.2K +17,887 +10%
Two Sigma Investments
34
Two Sigma Investments
New York
$505K +$461K +134,665 +317%
SCM
35
Stonepine Capital Management
Oregon
$443K +$190K +55,551 +56%
American Century Companies
36
American Century Companies
Missouri
$433K +$10.3K +3,010 +2%
Barclays
37
Barclays
United Kingdom
$394K -$61.3K -17,915 -11%
Wealth Enhancement Advisory Services
38
Wealth Enhancement Advisory Services
Minnesota
$392K +$471K +137,470 New
Two Sigma Advisers
39
Two Sigma Advisers
New York
$382K +$320K +93,500 +230%
Jane Street
40
Jane Street
New York
$372K +$289K +84,434 +184%
N
41
Nuveen
North Carolina
$352K – – –
N
42
Numerai
California
$351K +$422K +123,241 New
Invesco
43
Invesco
Georgia
$318K +$17.2K +5,037 +5%
AQR Capital Management
44
AQR Capital Management
Connecticut
$284K -$52.2K -15,256 -13%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$276K -$17.6K -5,130 -5%
BCM
46
Bridgeway Capital Management
Texas
$271K +$325K +95,000 New
Wells Fargo
47
Wells Fargo
California
$249K +$130K +37,883 +77%
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$235K – – –
HSBC Holdings
49
HSBC Holdings
United Kingdom
$234K +$4.36K +1,273 +2%
Bank of America
50
Bank of America
North Carolina
$229K -$61.1K -17,840 -18%
1
2
3 4 5

HCAT Hedge Fund Activity: Q3 2025 in Review

145 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q3 2025, worth a combined $154M — down 24% from $204M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new HCAT positions and 33 closed out — a net gain of 1 holder — while 42 added to existing stakes and 38 trimmed.

The largest buyer was Millennium Management, adding an estimated $5.23M. The largest seller was Portolan Capital Management, exiting entirely with an estimated $7.47M sold.

  • 145 institutional investors held Health Catalyst (HCAT) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $154M of Health Catalyst stock for Q3 2025, down 24% quarter-over-quarter.
  • 34 funds opened new Health Catalyst positions in Q3 2025 and 33 closed out, a net change of +1 holder.
  • The largest Health Catalyst buyer in Q3 2025 was Millennium Management, an estimated $5.23M added.
  • The largest Health Catalyst seller in Q3 2025 was Portolan Capital Management, an estimated $7.47M sold.

Based on aggregated 13F filings for Q3 2025.